MiX Telematics (MIXT) versus Epocrates (EPOC) Head to Head Analysis

MiX Telematics (NYSE: MIXT) and Epocrates (NASDAQ:EPOC) are both small-cap computer and technology companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, profitability, institutional ownership, analyst recommendations, dividends and earnings.

Institutional & Insider Ownership

27.1% of MiX Telematics shares are owned by institutional investors. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Earnings & Valuation

This table compares MiX Telematics and Epocrates’ top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
MiX Telematics $114.82 million 2.23 $8.65 million $0.40 28.65
Epocrates N/A N/A N/A ($0.30) -39.10

MiX Telematics has higher revenue and earnings than Epocrates. Epocrates is trading at a lower price-to-earnings ratio than MiX Telematics, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for MiX Telematics and Epocrates, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
MiX Telematics 0 2 1 0 2.33
Epocrates 0 0 0 0 N/A

MiX Telematics currently has a consensus target price of $15.00, indicating a potential upside of 30.89%. Given MiX Telematics’ higher probable upside, analysts plainly believe MiX Telematics is more favorable than Epocrates.

Dividends

MiX Telematics pays an annual dividend of $0.13 per share and has a dividend yield of 1.1%. Epocrates does not pay a dividend. MiX Telematics pays out 32.5% of its earnings in the form of a dividend.

Profitability

This table compares MiX Telematics and Epocrates’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
MiX Telematics 7.73% 8.99% 6.81%
Epocrates N/A N/A N/A

Summary

MiX Telematics beats Epocrates on 9 of the 10 factors compared between the two stocks.

About MiX Telematics

MiX Telematics Limited is a South Africa-based provider of fleet and mobile asset management solutions delivered as Software-as-a-Service (SaaS) to customers. The Company’s operating segments include Africa, Europe, Americas, Middle East and Australasia, Brazil and Central Services Organization. The Company’s products and services provide enterprise fleets, small fleets and consumers with solutions for safety, risk management and security. The Company’s solutions include MiX Fleet Manager, which consists of an on-board computer, an online tracking and information portal, as well as access to fleet and driver reports and analytics; MiX SafeDrive provides In-Vehicle Monitoring Systems (IVMS) that monitor driver performance, identify unsafe behaviors and provide audible alerts; Matrix is focused on personal safety and consumer telematics through vehicle tracking-and-recovery products and services, and Beam-e, which is a wireless device that fits into vehicles, motorbikes or caravan.

About Epocrates

Epocrates, Inc. (Epocrates) is a provider of mobile drug reference tools and electronic health records to healthcare professionals and interactive services to the healthcare industry. As of December 31, 2011, its user network consists of well over one million healthcare professionals, including approximately 340,000, or more than 50% of United States physicians. The Company offers its products on major United States mobile platforms, including Apple iOS, Android and BlackBerry. Epocrates operates in two segments: Subscriptions and Interactive Services, and Electronic Health Records. It uses brand names include DocAlert, Epocrates, Epocrates Honors, Epocrates ID, Epocrates Lab, Epocrates MedTools, Epocrates Rx, Epocrates Rx Pro, Epocrates Dx, Epocrates QuickSurvey, Epocrates QuickRecruit, Epocrates MedInsight, EssentialPoints and MedCafe. In October 2011, it launched a redesign of the drug reference tool to create a new platform that provides healthcare professionals.

Receive News & Ratings for MiX Telematics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MiX Telematics and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply